Dongli Yue

2.6k total citations · 1 hit paper
41 papers, 1.4k citations indexed

About

Dongli Yue is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Dongli Yue has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 21 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Dongli Yue's work include Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (9 papers) and Cancer Cells and Metastasis (8 papers). Dongli Yue is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (9 papers) and Cancer Cells and Metastasis (8 papers). Dongli Yue collaborates with scholars based in China, United States and Australia. Dongli Yue's co-authors include Yi Zhang, Liping Wang, Xinfeng Chen, Bin Zhang, Lan Huang, Ping Yü, Ling Cao, Lifeng Li, Feng Li and Qun Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Immunity and Cancer Research.

In The Last Decade

Dongli Yue

37 papers receiving 1.4k citations

Hit Papers

PD-1 signaling limits expression of phospholipid phosphat... 2024 2026 2025 2024 10 20 30 40 50

Peers

Dongli Yue
Yael Raz Israel
Adile Orhan Denmark
Jason E. Toombs United States
Tenghui Chen United States
Joel Crespo United States
Aiqin Gao China
Yael Raz Israel
Dongli Yue
Citations per year, relative to Dongli Yue Dongli Yue (= 1×) peers Yael Raz

Countries citing papers authored by Dongli Yue

Since Specialization
Citations

This map shows the geographic impact of Dongli Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongli Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongli Yue more than expected).

Fields of papers citing papers by Dongli Yue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongli Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongli Yue. The network helps show where Dongli Yue may publish in the future.

Co-authorship network of co-authors of Dongli Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Dongli Yue. A scholar is included among the top collaborators of Dongli Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongli Yue. Dongli Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Haofeng, et al.. (2025). Enhancing erosion-corrosion resistance of cupronickel alloys via Al-addition on microstructure and mechanistic. Materials & Design. 256. 114304–114304.
3.
Zhang, Yunqing, Huiying Li, Zhiqiang Zou, et al.. (2025). Protective effects and antioxidant mechanisms of lactobacillus combined with carnosine on the stomach and small intestine. Journal of Functional Foods. 125. 106687–106687. 1 indexed citations
4.
P, Yu, Feng Li, Jiao Qu, et al.. (2024). PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosis. Immunity. 57(9). 2122–2139.e9. 59 indexed citations breakdown →
5.
Gao, Qun, Feng Li, Jingyao Lian, et al.. (2022). High Mobility Group Protein B1 Decreases Surface Localization of PD-1 to Augment T-cell Activation. Cancer Immunology Research. 10(7). 844–855. 13 indexed citations
6.
Yue, Dongli, Shasha Liu, Tengfei Zhang, et al.. (2021). NEDD9 promotes cancer stemness by recruiting myeloidderived suppressor cells <i>via</i> CXCL8 in esophageal squamous cell carcinoma. Cancer Biology and Medicine. 18(3). 705–720. 25 indexed citations
7.
Yue, Dongli, Xiaojuan Shi, Shasha Liu, et al.. (2020). Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway. Frontiers in Oncology. 10. 311–311. 11 indexed citations
8.
Song, Mengjia, Ping Yü, Kai Zhang, et al.. (2019). Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non–Small Cell Lung Cancer. Cancer Research. 79(14). 3737–3748. 113 indexed citations
9.
Wang, Dong, Yang Li, Dongli Yue, et al.. (2019). Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion. Cancer Letters. 452. 244–253. 149 indexed citations
10.
Shi, Xiaojuan, Xinfeng Chen, Ping Yü, et al.. (2019). Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma. Biomedicine & Pharmacotherapy. 112. 108632–108632. 23 indexed citations
11.
Chen, Xinfeng, Liping Wang, Mengjia Song, et al.. (2018). Dual TGF‐β and PD‐1 blockade synergistically enhances MAGE‐A3‐specific CD8+ T cell response in esophageal squamous cell carcinoma. International Journal of Cancer. 143(10). 2561–2574. 76 indexed citations
12.
Qin, Guohui, Jingyao Lian, Dongli Yue, et al.. (2017). Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma. Oncology Reports. 38(3). 1724–1732. 15 indexed citations
13.
He, Jing, Mingxia Zhou, Xinfeng Chen, et al.. (2016). Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research. 35(1). 98–98. 72 indexed citations
14.
Li, Hong, Lan Huang, Linbo Liu, et al.. (2016). Selective effect of cytokine-induced killer cells on survival of patients with early-stage melanoma. Cancer Immunology Immunotherapy. 66(3). 299–308. 9 indexed citations
15.
Yue, Dongli, Zhen Zhang, Jieyao Li, et al.. (2015). Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer. Experimental Cell Research. 336(1). 141–149. 40 indexed citations
16.
Wang, Meng, Jiansheng Li, Ping Yü, et al.. (2015). The host HLA-A*02 allele is associated with the response to pegylated interferon and ribavirin in patients with chronic hepatitis C virus infection. Archives of Virology. 160(4). 1043–1054. 3 indexed citations
17.
Zhao, Xianlan, Tengfei Zhang, Liping Wang, et al.. (2014). Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood. Cytotherapy. 17(1). 86–97. 19 indexed citations
18.
Yue, Dongli, Xinfeng Chen, Liping Wang, et al.. (2014). Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacity. Oncology Reports. 33(1). 425–432. 35 indexed citations
19.
Yue, Dongli, Qingxia Fan, Xinfeng Chen, et al.. (2013). Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma. Experimental Cell Research. 322(1). 149–158. 26 indexed citations
20.
Dong, Wenjie, et al.. (2011). Inactivation of MYO5B Promotes Invasion and Motility in Gastric Cancer Cells. Digestive Diseases and Sciences. 57(5). 1247–1252. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026